Stockreport

Trovagene up 48% on positive onvansertib data [Seeking Alpha]

TROVAGENE  (TROV) 
Last trovagene earnings: 3/6 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: trovagene.com
PDF Thinly traded nano cap Trovagene (NASDAQ:TROV48%interim dataPhase 1/2 clinical trialAt data cutoff, 88% (n=7/8) of treated patients experienced at least stable cancer. T [Read more]